Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pliant Therapeutics, Inc.

1.60
-0.0300-1.84%
Post-market: 1.600.00000.00%18:45 EDT
Volume:810.40K
Turnover:1.29M
Market Cap:98.22M
PE:-0.44
High:1.68
Open:1.65
Low:1.55
Close:1.63
Loading ...

Pliant Therapeutics Approves Key Proposals at Annual Meeting

TIPRANKS
·
8 hours ago

Pliant Therapeutics Inc. Held Annual Stockholders Meeting

Reuters
·
8 hours ago

Piper Sandler Keeps Their Buy Rating on Pliant Therapeutics (PLRX)

TIPRANKS
·
09 May

Oppenheimer Sticks to Its Hold Rating for Pliant Therapeutics (PLRX)

TIPRANKS
·
09 May

Pliant Therapeutics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
09 May

BRIEF-Pliant Therapeutics Q1 Net Income USD -56.166 Million

Reuters
·
09 May

Pliant Therapeutics Inc: Strategic Realignment of Workforce and Ops Will Extend Cash Runway to Support Late-Stage Clinical Trials

THOMSON REUTERS
·
09 May

Pliant Therapeutics: Announced Realignment of Its Operations Including About 45% Reduction in Its Workforce

THOMSON REUTERS
·
09 May

Pliant Therapeutics to lay off 45% of Workforce in Restructuring Move

MT Newswires Live
·
02 May

Pliant Therapeutics Inc expected to post a loss of 72 cents a share - Earnings Preview

Reuters
·
02 May

Pliant Therapeutics Reduces Workforce as Part of Strategic Realignment

Dow Jones
·
02 May

Pliant Therapeutics to reduce workforce by 45%

TIPRANKS
·
02 May

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

THOMSON REUTERS
·
02 May

Pliant Therapeutics Inc - Restructuring Expected to Complete by End of Q2 2025

THOMSON REUTERS
·
02 May

Pliant Therapeutics Inc - Topline Data From Beacon-Ipf Trial Expected Q2 2025

THOMSON REUTERS
·
02 May

Pliant Therapeutics Inc - to Announce Q1 2025 Results on May 8

THOMSON REUTERS
·
02 May

Pliant Therapeutics Inc - to Reduce Workforce by Approximately 45%

THOMSON REUTERS
·
02 May

Pliant Therapeutics Announces Strategic Realignment of Workforce and Operations

GlobeNewswire
·
02 May

PLIANT THERAPT (PLRX) Upgraded to Buy: Here's What You Should Know

Zacks
·
11 Apr

Pliant Therapeutics Inc: Pln-101095 Was Generally Well Tolerated Across All Doses

THOMSON REUTERS
·
17 Mar